指南与共识胰腺与胆道疾病消化内镜消化道肿瘤与早癌

ASGE指南:内镜在恶性肝门部胆道梗阻管理中的作用

ASGE guideline on the role of endoscopy in the management of malignant hilar obstruction.
指南 / 共识 · Gastrointest Endosc · 2021-05-20

美国胃肠内镜学会(ASGE)基于GRADE框架制定本指南,针对恶性肝门部梗阻(MHO)的引流方式(PTBD vs EBD)、引流策略(单侧 vs 双侧)及支架选择(PS vs SEMS)提出推荐。指南建议潜在可切除患者一线避免常规PTBD,不可切除姑息引流可选PTBD或EBD,无肝萎缩时倾向双侧支架,短预期寿命且重视避免重复干预者倾向SEMS。

要点

  • 潜在可切除MHO引流避免常规首选PTBD,推荐EBD
  • 不可切除MHO姑息引流可选PTBD或EBD,需个体化决策
  • 无肝萎缩的不可切除MHO姑息支架置入倾向双侧支架

核心结论

  • ASGE基于GRADE框架对MHO的内镜管理提出循证推荐,涵盖引流方式、引流策略和支架选择。

研究设计与样本

  • 制定机构为美国胃肠内镜学会(ASGE),采用GRADE框架制定临床指南。

主要发现

  • 潜在可切除MHO引流前,面板建议避免常规首选PTBD而选择EBD。
  • 不可切除MHO姑息引流,面板建议PTBD或EBD,最终决策基于患者偏好、疾病特征和本地经验。
  • 不可切除MHO无肝萎缩时姑息支架置入,面板建议双侧支架而非单侧支架。
  • 不可切除MHO姑息支架置入,面板建议SEMS或PS;短预期寿命且重视避免重复干预者建议SEMS而非PS。
  • 最佳引流策略未确立时,面板建议置入PS。

关键数值与推荐

  • 潜在可切除MHO引流:避免常规首选PTBD(对比EBD)。
  • 不可切除MHO姑息引流:PTBD或EBD均可。
  • 不可切除MHO无肝萎缩姑息支架:建议双侧支架(对比单侧)。
  • 不可切除MHO姑息支架:SEMS或PS均可;短预期寿命且重视避免重复干预者建议SEMS(对比PS)。
  • 最佳引流策略未确立时:建议PS。

临床怎么用

  • 潜在可切除MHO患者引流应优先考虑EBD而非PTBD。
  • 不可切除MHO姑息引流需结合患者偏好、疾病特征和本地技术条件选择PTBD或EBD。
  • 无肝萎缩的不可切除MHO姑息支架置入可考虑双侧支架。
  • 短预期寿命且希望避免重复干预的患者优先选择SEMS。
  • 引流策略未明确时选用PS。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This clinical guideline from the American Society for Gastrointestinal Endoscopy (ASGE) provides an evidence-based approach for the management of patients with malignant hilar obstruction (MHO). This document was developed using the Grading of Recommendations Assessment, Development and Evaluation framework and addresses primary drainage modality (percutaneous transhepatic biliary drainage [PTBD] vs endoscopic biliary drainage [EBD]), drainage strategy (unilateral vs bilateral), and stent selection (plastic stent [PS] vs self-expandable metal stent [SEMS]). Regarding drainage modality, in patients with MHO undergoing drainage before potential resection or transplantation, the panel suggests against routine use of PTBD as first-line therapy compared with EBD. In patients with unresectable MHO undergoing palliative drainage, the panel suggests PTBD or EBD. The final decision should be based on patient preferences, disease characteristics, and local expertise. Regarding drainage strategy, in patients with unresectable MHO undergoing palliative stent placement, the panel suggests placement of bilateral stents compared with a unilateral stent in the absence of liver atrophy. Finally, regarding type of stent, in patients with unresectable MHO undergoing palliative stent placement, the panel suggests placing SEMSs or PSs. However, in patients who have a short life expectancy and who place high value on avoiding repeated interventions, the panel suggests using SEMSs compared with PSs. If optimal drainage strategy has not been established, the panel suggests placing PSs. This document clearly outlines the process, analyses, and decision processes used to reach the final recommendations and represents the official ASGE recommendations on the above topics.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Qumseya BJ, Jamil LH, Elmunzer BJ, et al. ASGE guideline on the role of endoscopy in the management of malignant hilar obstruction. Gastrointest Endosc. 2021. PMID: 34023067. doi:10.1016/j.gie.2020.12.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。